Donetta Lee Sinard, APRN, NPC

Donetta Sinard practices at Tennessee Oncology in Chattanooga, Tennessee.

Donetta Sinard's NPI, 1073175311, was assigned on July 8, 2019. Donetta Sinard holds Tennessee license APN0000026048.

Donetta Sinard's primary practice is Tennessee Oncology, at 605 Glenwood Dr, Chattanooga, TN 37404 in Hamilton County. The practice phone is (615) 329-0570.

Donetta Sinard's primary practice is Tennessee Oncology in Chattanooga, Tennessee. Donetta Sinard is also affiliated with The University of Tennessee Medical Center. The medical group on file is Tennessee Oncology. Dmand AI also links Donetta Sinard to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Donetta Sinard practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Donetta Sinard's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Donetta Sinard is licensed in Tennessee.

CMS counts 230 Medicare patients who saw Donetta Sinard in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Donetta Sinard's median patient age at 65, with 60% women.

In 2024, Donetta Sinard wrote 358 Medicare Part D claims for 118 patients. 78% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Donetta Sinard for performance year 2024, reported through an alternative payment model (APM). Donetta Sinard accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 32 general payments to Donetta Sinard from 18 drug and device companies in 2025. Food and beverage make up the largest share, 87% of the total. Janssen Pharmaceuticals, Inc paid the most, $136.